logo
  

Primerica Counters Misleading Blog, Defends Integrity Of Business Operations

Primerica Inc. (PRI), a financial services provider across the United States and Canada, has responded to a recent blog post containing false claims aimed at lowering the company's stock price.

The company asserts that the blog's assertions misrepresent Primerica's commitment to assisting middle-income families through its licensed sales force.

Primerica views the blog as a self-serving attempt to manipulate stock prices to the detriment of its shareholders.

For more than 47 years, Primerica has provided financial products and services to households in the United States and Canada. The company protect over 5.7 million lives with life insurance and paid over $1.8 billion in claims to the families of
clients last year. It also has 2.9 million clients who trust the company with almost
$100 billion of investments, Primerica said in a statement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, Kraft Heinz Co. (KHC) reaffirmed its adjusted earnings and organic net sales growth guidance for the full-year 2024. For fiscal 2024, the company still projects adjusted earnings in a range of $3.01 to $3.07 per share on organic... While reporting financial results for the first quarter, drug major Pfizer Inc. (PFE) raised its adjusted earnings guidance for the full-year 2024, while maintaining annual revenue outlook. For fiscal 2024, the company now projects adjusted earnings in a range of $2.15 to $2.35 per share, up from... While reporting financial results for the first quarter on Wednesday, CVS Health (CVS) slashed its earnings and adjusted earnings guidance for the full-year 2024, reflecting the potential for continued elevated medical cost trends in the remainder of 2024. For fiscal 2024, the company now projects...

This week, we feature OJEMDA’s FDA approval, Bristol Myer’s Job cuts, Novo Nordisk’s increased pricing of drugs in US, Incyte’s strategic acquisition, and Ireland’s Alcohol labels.

View More Videos
Follow RTT